首页|期刊导航|Bone Research|Evidence of bisphosphonate-conjugated sitafloxacin eradication of established methicillin-resistant S.aureus infection with osseointegration in murine models of implant-associated osteomyelitis
Evidence of bisphosphonate-conjugated sitafloxacin eradication of established methicillin-resistant S.aureus infection with osseointegration in murine models of implant-associated osteomyelitis
Youliang Ren Jason Weeks Thomas Xue Joshua Rainbolt Karen L.de Mesy Bentley Ye Shu Yuting Liu Elysia Masters Philip Cherian Charles E.McKenna Jeffrey Neighbors Frank H.Ebetino Edward M.Schwarz Shuting Sun Chao Xie
Bone Research2023,Vol.11Issue(4):P.751-763,13.
Bone Research2023,Vol.11Issue(4):P.751-763,13.DOI:10.1038/s41413-023-00287-4
Evidence of bisphosphonate-conjugated sitafloxacin eradication of established methicillin-resistant S.aureus infection with osseointegration in murine models of implant-associated osteomyelitis
摘要
关键词
implant/infection/overcome分类
医药卫生引用本文复制引用
Youliang Ren,Jason Weeks,Thomas Xue,Joshua Rainbolt,Karen L.de Mesy Bentley,Ye Shu,Yuting Liu,Elysia Masters,Philip Cherian,Charles E.McKenna,Jeffrey Neighbors,Frank H.Ebetino,Edward M.Schwarz,Shuting Sun,Chao Xie..Evidence of bisphosphonate-conjugated sitafloxacin eradication of established methicillin-resistant S.aureus infection with osseointegration in murine models of implant-associated osteomyelitis[J].Bone Research,2023,11(4):P.751-763,13.基金项目
supported by grants from the National Institutes of Health(SBIR R44 AI125060,NIAMS P50 AR072000,and NIAMS P30 AR069655)。 (SBIR R44 AI125060,NIAMS P50 AR072000,and NIAMS P30 AR069655)